1. Inicio
  2. Proyectos y Estudios
  3. A Phase 2a double blind, randomized, parallel arm, placebocontrolled trial to investigate the effects of two dose levels of CIT-013 on disease activity in patients with Hidradenitis Suppurativa (HS) (Citylights).

A Phase 2a double blind, randomized, parallel arm, placebocontrolled trial to investigate the effects of two dose levels of CIT-013 on disease activity in patients with Hidradenitis Suppurativa (HS) (Citylights).

Datos básicos

ENSAYO CLÍNICO CITRYLL003 HOSPITAL DE MANISES Año de incio: 2026

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

CITRYLL BV,

Compartir